National Research (NASDAQ:NRC) Stock Passes Above 200-Day Moving Average – Here’s Why

National Research Corporation (NASDAQ:NRC) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $17.63 and traded as high as $18.59. National Research shares last traded at $18.47, with a volume of 84,418 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.

National Research Price Performance

The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48. The firm’s fifty day moving average price is $18.41 and its 200 day moving average price is $17.64. The stock has a market cap of $421.79 million, a PE ratio of 47.54 and a beta of 0.37.

National Research (NASDAQ:NRC) last posted its earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share for the quarter. The company had revenue of $34.80 million during the quarter. National Research had a net margin of 6.52% and a return on equity of 122.73%.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 10th. Stockholders of record on Friday, June 26th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, June 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.5%. National Research’s dividend payout ratio (DPR) is presently 164.10%.

Institutional Investors Weigh In On National Research

Hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. boosted its stake in National Research by 85.6% during the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after buying an additional 921 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in National Research by 9,535.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock worth $28,000 after acquiring an additional 1,621 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in shares of National Research by 85.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after acquiring an additional 1,150 shares in the last quarter. Strs Ohio purchased a new stake in shares of National Research during the 1st quarter worth approximately $33,000. Finally, Raymond James Financial Inc. bought a new position in shares of National Research during the 2nd quarter valued at approximately $34,000. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.